ST恒久(002808) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥71,019,067.84, a decrease of 20.55% year-on-year[8] - Net profit attributable to shareholders was ¥4,884,489.04, down 53.60% compared to the same period last year[8] - Basic earnings per share decreased by 53.57% to ¥0.0182[8] - The company's operating revenue for Q3 2019 was CNY 59,678,631.80, a decrease of 16.5% compared to CNY 71,426,429.37 in the same period last year[39] - The net profit for Q3 2019 was CNY 4,884,489.04, down 53.7% from CNY 10,527,713.50 in Q3 2018[39] - The total comprehensive income for Q3 2019 was CNY 5,278,491.91, a decline of 51.3% compared to CNY 10,842,792.99 in the previous year[37] - The company's operating profit for Q3 2019 was CNY 6,384,682.57, down 48.7% from CNY 12,447,717.06 in Q3 2018[39] - The total revenue for the year-to-date period was CNY 211,067,674.06, a decrease of 6.1% from CNY 224,816,316.92 in the previous year[41] - The company's total assets as of September 30, 2019, were CNY 619,024,575.27, slightly up from CNY 612,156,477.49 at the end of 2018[33] Cash Flow - Net cash flow from operating activities increased significantly by 185.50% to ¥15,289,133.15 during the reporting period[8] - Net cash flow from operating activities improved significantly to ¥28,192,486.00 in the first nine months of 2019, a turnaround from a negative cash flow of ¥60,924,261.38 in the same period of 2018, representing a 146.27% increase[25] - The cash flow from operating activities was CNY 221,554,582.68, slightly up from CNY 214,037,520.49 in the previous period[50] - Total cash inflow from operating activities amounted to 282,656,991.70 CNY, up from 234,602,794.69 CNY year-over-year[51] - Cash outflow from operating activities decreased to 254,464,505.70 CNY from 295,527,056.07 CNY, indicating better cost management[51] - The net cash flow from investing activities was -17,176,998.92 CNY, an improvement from -39,914,033.82 CNY in the previous period[52] - The net cash flow from financing activities was -1,766,887.53 CNY, compared to a positive 51,138,883.23 CNY in the previous period[56] Assets and Liabilities - Total assets at the end of the reporting period reached ¥696,818,728.90, an increase of 1.38% compared to the end of the previous year[8] - The total liabilities increased to CNY 124,295,028.67 from CNY 120,714,522.11 in the previous period[28] - The company's total liabilities and owner's equity amounted to CNY 696,818,728.90, up from CNY 687,339,463.82[28] - Current liabilities totaled CNY 119,496,957.88, including short-term borrowings of CNY 60,000,000.00 and accounts payable of CNY 49,709,548.09[60] - Total liabilities reached CNY 120,714,522.11, with non-current liabilities at CNY 1,217,564.23[61] - The company has long-term equity investments valued at CNY 37,147,586.86 and fixed assets worth CNY 100,336,397.91[59] Shareholder Information - The company reported a total of 15,768 common shareholders at the end of the reporting period[12] - The largest shareholder, Yu Rongqing, holds 39.52% of the shares, totaling 106,240,512 shares[12] - The company did not engage in any repurchase transactions during the reporting period[13] Investment and Expenses - Investment income dropped significantly by 538.05% to ¥-6,419,065.75, compared to ¥1,465,379.13 in the previous year, mainly due to a decrease in equity method investment income[25] - Research and development expenses for Q3 2019 amounted to CNY 3,476,578.96, compared to CNY 3,709,374.98 in the previous period[35] - The company's R&D expenses for Q3 2019 were CNY 7,371,399.18, down from CNY 8,307,559.74 in the previous year[47] Financial Stability - The company has no overdue commitments or guarantees during the reporting period, indicating a stable financial position[19] - The company has not engaged in any significant investment activities or acquisitions during the reporting period, focusing on internal growth strategies[18] - The company has made adjustments to its financial assets, reclassifying available-for-sale financial assets to other equity instrument investments[61]